首页 / 院系成果 / 成果详情页

A multicenter, open-label, single-arm, phase II trial to evaluate the efficacy and safety of geptanolimab (GB226) in the treatment of patients (pts) with programmed cell death ligand 1 (PD-L1)-positive recurrent or metastatic cervical cancer, for whom prior platinum-containing chemotherapy has failed  会议论文 期刊论文  

  • 编号:
    6EC9D727CF9DF0FAAA36B51D2150CA92
  • 作者:
    An, Jusheng(安菊生); Zhang, Yunyan;Feng, Mei;Zhang, Keqiang;Zhu, Jianqing;He, Aiqin;Li, Xiumin;Peng, Jin;Wang, Xinwen;Zhang, Hongping;Kong, Weimin;Li, Guiling(李贵玲); Yuan, Jianlin;Yu, Shiying;Liu, Hu;Ma, Cailing(马彩玲); Chen, Hongmin(陈红敏); Shen, Liangfang;Xie, Fan;Wu, Lingying(吴令英);
  • 语种:
    英文
  • 会议名称:
    JOURNAL OF CLINICAL ONCOLOGY
  • 收录:
  • 推荐引用方式
    GB/T 7714:
    An Jusheng,Zhang Yunyan,Feng Mei, et al. A multicenter, open-label, single-arm, phase II trial to evaluate the efficacy and safety of geptanolimab (GB226) in the treatment of patients (pts) with programmed cell death ligand 1 (PD-L1)-positive recurrent or metastatic cervical cancer, for whom prior platinum-containing chemotherapy has failed [J].JOURNAL OF CLINICAL ONCOLOGY,2023,41(16).
  • APA:
    An Jusheng,Zhang Yunyan,Feng Mei,Zhang Keqiang,&Wu Lingying.(2023).A multicenter, open-label, single-arm, phase II trial to evaluate the efficacy and safety of geptanolimab (GB226) in the treatment of patients (pts) with programmed cell death ligand 1 (PD-L1)-positive recurrent or metastatic cervical cancer, for whom prior platinum-containing chemotherapy has failed .JOURNAL OF CLINICAL ONCOLOGY,41(16).
  • MLA:
    An Jusheng, et al. "A multicenter, open-label, single-arm, phase II trial to evaluate the efficacy and safety of geptanolimab (GB226) in the treatment of patients (pts) with programmed cell death ligand 1 (PD-L1)-positive recurrent or metastatic cervical cancer, for whom prior platinum-containing chemotherapy has failed" .JOURNAL OF CLINICAL ONCOLOGY 41,16(2023).
  • 入库时间:
    2023/10/4 19:20:38
  • 更新时间:
    2023/10/4 19:20:38
浏览次数:23 下载次数:0
浏览次数:23
下载次数:0
打印次数:0
浏览器支持: Google Chrome   火狐   360浏览器极速模式(8.0+极速模式) 
返回顶部